Mycophenolate Mofetil EP Reference Standard
European Pharmacopoeia reference standard of mycophenolate mofetil used for analytical method validation and quality control testing. As a chemically defined aromatic heterocyclic compound, it precisely matches HTS 2934.99.01.00 specifications. Supplied in certified amounts (typically 100mg vials) for HPLC/GC calibration.
Import Duty Rates by Country of Origin
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If for diagnostic laboratory reagents
Reference standards used in clinical testing may classify as diagnostic reagents.
If heavy water or isotopic compounds
Labeled versions for metabolic studies could classify under isotopes.
If hormone precursors or factors
Immunomodulatory classification might lead to hormones heading consideration.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Include EP certificate confirming traceability to primary reference standard with assigned purity value
• Declare as 'reference standard for laboratory analysis only' to avoid pharmaceutical API scrutiny
• Small package exemption may apply for quantities <100g if properly documented as analytical reagent
Related Products under HTS 2934.99.01.00
Mycophenolate Mofetil Hydrochloride
Mycophenolate mofetil hydrochloride is the hydrochloride salt form of mycophenolate mofetil, a semi-synthetic immunosuppressant derived from mycophenolic acid with a morpholinoethyl ester group. It falls under HTS 2934.99.01.00 as a specific aromatic heterocyclic compound used primarily to prevent organ transplant rejection by inhibiting lymphocyte proliferation. This chemically defined compound contains a fused heterocyclic ring system characteristic of Chapter 29 heading 2934.
Mycophenolate Mofetil Free Base Powder
Pure mycophenolate mofetil free base in pharmaceutical-grade powder form serves as the active pharmaceutical ingredient (API) for generic immunosuppressant production. Classified under HTS 2934.99.01.00 as the specific aromatic heterocyclic compound, it features the characteristic morpholinoester structure on the mycophenolic acid backbone. Used exclusively in manufacturing formulations for preventing organ rejection.
Pharmaceutical Grade Mycophenolate Mofetil USP
Mycophenolate mofetil meeting United States Pharmacopeia (USP) standards for use in FDA-approved generic drug manufacturing. This specific aromatic heterocyclic immunosuppressant falls under HTS 2934.99.01.00 per Chapter 29 notes for chemically defined organic compounds. The product's fused ring system with ester functionality defines its precise tariff classification.
Bulk Mycophenolate Mofetil API for Generic Production
Large-quantity bulk API mycophenolate mofetil specifically manufactured for generic pharmaceutical production of transplant rejection medications. Falls under HTS 2934.99.01.00 as the named aromatic heterocyclic compound per Chapter 29 legal notes. Chemically defined with specific morpholinoethyl ester structure distinguishing from other mycophenolic derivatives.
Mycophenolate Mofetil Morpholino Ester
The specific morpholinoethyl ester prodrug form of mycophenolic acid, chemically defined as mycophenolate mofetil under HTS 2934.99.01.00. This aromatic heterocyclic compound converts in vivo to active mycophenolic acid via esterase cleavage. Essential API for branded CellCept® and generic equivalents.
Sterile Mycophenolate Mofetil for Injection Formulation
Sterile-grade mycophenolate mofetil powder intended for IV injection formulation after further processing. Classified under HTS 2934.99.01.00 as bulk aromatic heterocyclic API despite sterile processing, per Chapter 29 notes excluding only finished medicaments. Meets parenteral quality standards with endotoxin limits <0.5 EU/mg.